Progress toward cell-directed therapy for phenylketonuria

Tekijä Harding, CO
Julkaistu 2008

Metabolic engineering as therapy for inborn errors of metabolism – development of mice with phenylalanine hydroxylase expression in muscle

Tekijä Harding, CO, Wild, K, Chang, D, Messing, A, Wolff, JA
Julkaistu 1998

Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria

Tekijä Harding, CO, Gillingham, MB, Hamman, K, Clark, H, Goebel-Daghighi, E, Bird, A, Koeberl, DD
Julkaistu 2006

Ammonia Control in Children Ages 2 Months through 5 Years with Urea Cycle Disorders: Comparison of Sodium Phenylbutyrate and Glycerol Phenylbutyrate

Tekijä Smith, W, Diaz, GA, Lichter-Konecki, U, Berry, SA, Harding, CO, McCandless, SE, LeMons, C, Mauney, J, Dickinson, K, Coakley, DF, Moors, TL, Mokhtarani, M, Mokhtarani, M, Scharschmidt, BF, Lee, B
Julkaistu 2013

GLUTAMINE AND HYPERAMMONEMIC CRISES IN PATIENTS WITH UREA CYCLE DISORDERS

Tekijä Lee, B., Diaz, G.A., Rhead, W., Lichter-Konecki, U., Feigenbaum, A., Berry, S.A., Le Mons, C., Bartley, J., Longo, N., Nagamani, S.C., Berquist, W., Gallagher, R.C., Harding, C.O., McCandless, S.E., Smith, W., Schulze, A., Marino, M., Rowell, R., Coakley, D.F., Mokhtarani, M., Scharschmidt, B.F.
Julkaisussa Mol Genet Metab (2015)

Urinary Phenylacetylglutamine as Dosing Biomarker for Patients with Urea Cycle Disorders

Tekijä Mokhtarani, M, Diaz, GA, Rhead, W, Lichter-Konecki, U, Bartley, J, Feigenbaum, A, Longo, N, Berquist, W, Berry, SA, Gallagher, R, Bartholomew, D, Harding, CO, Korson, MS, McCandless, SE, Smith, W, Vockley, J, Bart, S, Kronn, D, Zori, R, Cederbaum, S, Dorrani, N, Merritt, JL, Sreenath-Nagamani, Sandesh, Summar, M, LeMons, C, Dickinson, K, Coakley, DF, Moors, TL, Lee, B, Scharschmidt, BF
Julkaistu 2012